Significant Publications on Infectious Diseases Pharmacotherapy in 2016

J Pharm Pract. 2018 Oct;31(5):469-480. doi: 10.1177/0897190017727212. Epub 2017 Aug 29.

Abstract

Purpose: This is a summary of the most important articles on infectious diseases (ID) pharmacotherapy published in peer-reviewed literature in 2016 as selected by clinical pharmacists with ID expertise.

Summary: The Houston Infectious Diseases Network (HIDN) was asked to identify articles published in peer-reviewed literature in 2016 that were believed to contribute significantly to ID pharmacotherapy, including human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS). A list of 46 articles on general ID pharmacotherapy and 8 articles on HIV/AIDS were nominated. Members of the Society of Infectious Diseases Pharmacists (SIDP) were surveyed to select 10 general ID articles believed to have made a significant impact on general ID pharmacotherapy and 1 article most significant to HIV/AIDS pharmacotherapy. Of 445 SIDP members surveyed, 212 (47.6%) and 95 (21.3%) members voted for general ID pharmacotherapy- and HIV/AIDS-related articles, respectively. The 11 highest-ranked papers (10 general ID-related articles and 1 HIV/AIDS-related article) are summarized here.

Conclusion: With the large number of ID-related articles published each year, it can be challenging to stay current with the most relevant ID publications. This review of significant publications in 2016 may provide a starting point for that process.

Keywords: anti-infectives; drug therapy; infectious disease; pharmacotherapy; publications.

Publication types

  • Review

MeSH terms

  • Anti-Infective Agents / therapeutic use*
  • Antimicrobial Stewardship / methods
  • Antimicrobial Stewardship / trends*
  • Communicable Diseases / drug therapy*
  • Communicable Diseases / epidemiology
  • HIV Infections / drug therapy
  • HIV Infections / epidemiology
  • Humans
  • Peer Review / methods
  • Peer Review / trends*
  • Periodicals as Topic / trends*
  • Practice Guidelines as Topic
  • Societies, Pharmaceutical / trends

Substances

  • Anti-Infective Agents